[
  {
    "ts": null,
    "headline": "Bio-Techne Corp. stock outperforms competitors on strong trading day",
    "summary": "Bio-Techne Corp. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=5816768b6e3b75442ceacacb2755653a44cc641568b934861e6cdca1cafede4b",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746724920,
      "headline": "Bio-Techne Corp. stock outperforms competitors on strong trading day",
      "id": 134358923,
      "image": "",
      "related": "TECH",
      "source": "MarketWatch",
      "summary": "Bio-Techne Corp. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=5816768b6e3b75442ceacacb2755653a44cc641568b934861e6cdca1cafede4b"
    }
  },
  {
    "ts": null,
    "headline": "Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing",
    "summary": "Kytopen Corp., a leader in providing continuous flow cellular engineering technologies and Bio-Techne Corporation (NASDAQ: TECH), a leading provider of innovative life science research tools today announced a partnership aimed at streamlining gene delivery solutions for the development and manufacture of advanced cell therapies. The collaboration will focus on the synergies developers can achieve by utilizing the TcBuster™ GMP non-viral genome engineering system and the Flowfect Tx™ GMP cellular",
    "url": "https://finnhub.io/api/news?id=c84577f82c9e826c521a5283bfa035fbe81f5d9d010c8c0f5e67fdc950cca6ca",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746711000,
      "headline": "Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing",
      "id": 134325695,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TECH",
      "source": "Yahoo",
      "summary": "Kytopen Corp., a leader in providing continuous flow cellular engineering technologies and Bio-Techne Corporation (NASDAQ: TECH), a leading provider of innovative life science research tools today announced a partnership aimed at streamlining gene delivery solutions for the development and manufacture of advanced cell therapies. The collaboration will focus on the synergies developers can achieve by utilizing the TcBuster™ GMP non-viral genome engineering system and the Flowfect Tx™ GMP cellular",
      "url": "https://finnhub.io/api/news?id=c84577f82c9e826c521a5283bfa035fbe81f5d9d010c8c0f5e67fdc950cca6ca"
    }
  },
  {
    "ts": null,
    "headline": "Bio-Techne to Present at the BofA Securities 2025 Health Care Conference",
    "summary": "Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present at the BofA Securities 2025 Health Care Conference on Tuesday, May 13, 2025, at 10:40 a.m. PDT. A live webcast of the presentation can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.",
    "url": "https://finnhub.io/api/news?id=2939b8f060f799d5e6393016c0d60084fe21e813ba39e4ecd337c2d30cb16a4d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746702000,
      "headline": "Bio-Techne to Present at the BofA Securities 2025 Health Care Conference",
      "id": 134325696,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TECH",
      "source": "Yahoo",
      "summary": "Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present at the BofA Securities 2025 Health Care Conference on Tuesday, May 13, 2025, at 10:40 a.m. PDT. A live webcast of the presentation can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.",
      "url": "https://finnhub.io/api/news?id=2939b8f060f799d5e6393016c0d60084fe21e813ba39e4ecd337c2d30cb16a4d"
    }
  },
  {
    "ts": null,
    "headline": "Kytopen Corp. and Bio-Techne Corporation Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing",
    "summary": "Kytopen Corp. and Bio-Techne Corporation announced a partnership aimed at streamlining gene delivery solutions for the development and manufacture of advanced cell therapies. The collaboration will...",
    "url": "https://finnhub.io/api/news?id=e372189548e0b4adc518a34e450c26fc3b7f10cc4e78258a2e64801fc14e5b49",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746696600,
      "headline": "Kytopen Corp. and Bio-Techne Corporation Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing",
      "id": 134324201,
      "image": "",
      "related": "TECH",
      "source": "Finnhub",
      "summary": "Kytopen Corp. and Bio-Techne Corporation announced a partnership aimed at streamlining gene delivery solutions for the development and manufacture of advanced cell therapies. The collaboration will...",
      "url": "https://finnhub.io/api/news?id=e372189548e0b4adc518a34e450c26fc3b7f10cc4e78258a2e64801fc14e5b49"
    }
  },
  {
    "ts": null,
    "headline": "Bio-Techne Corp (TECH) Q3 2025 Earnings Call Highlights: Strong Organic Growth Amid Global ...",
    "summary": "Bio-Techne Corp (TECH) reports a 6% organic revenue increase and robust performance in protein sciences, despite facing macroeconomic uncertainties and tariff impacts.",
    "url": "https://finnhub.io/api/news?id=71900b843e3b03a03c81cd21984b0abee6273faed9e4dbd48c37f4ad37e90cf8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746688569,
      "headline": "Bio-Techne Corp (TECH) Q3 2025 Earnings Call Highlights: Strong Organic Growth Amid Global ...",
      "id": 134317606,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TECH",
      "source": "Yahoo",
      "summary": "Bio-Techne Corp (TECH) reports a 6% organic revenue increase and robust performance in protein sciences, despite facing macroeconomic uncertainties and tariff impacts.",
      "url": "https://finnhub.io/api/news?id=71900b843e3b03a03c81cd21984b0abee6273faed9e4dbd48c37f4ad37e90cf8"
    }
  },
  {
    "ts": null,
    "headline": "Transcript : Bio-Techne Corporation Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 10",
    "summary": "Presenter SpeechUnknown Analyst I'm joined by Kim Kelderman, Chief Executive Officer; and Jim Hippel, Chief Financial Officer. Gentlemen, thanks for being here.Presenter SpeechKim Kelderman Thanks",
    "url": "https://finnhub.io/api/news?id=c27f06b7205e6d1313564c12f7e07ef61db46bda96c0e48260c32381d40915c4",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746687600,
      "headline": "Transcript : Bio-Techne Corporation Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 10",
      "id": 134405482,
      "image": "",
      "related": "TECH",
      "source": "Finnhub",
      "summary": "Presenter SpeechUnknown Analyst I'm joined by Kim Kelderman, Chief Executive Officer; and Jim Hippel, Chief Financial Officer. Gentlemen, thanks for being here.Presenter SpeechKim Kelderman Thanks",
      "url": "https://finnhub.io/api/news?id=c27f06b7205e6d1313564c12f7e07ef61db46bda96c0e48260c32381d40915c4"
    }
  },
  {
    "ts": null,
    "headline": "Q3 2025 Bio-Techne Corp Earnings Call",
    "summary": "Q3 2025 Bio-Techne Corp Earnings Call",
    "url": "https://finnhub.io/api/news?id=f096cae9d8b892a0671095521c3339dfd375495aa09b5cdfdbb2d8d961fe6a99",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746683064,
      "headline": "Q3 2025 Bio-Techne Corp Earnings Call",
      "id": 134317607,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TECH",
      "source": "Yahoo",
      "summary": "Q3 2025 Bio-Techne Corp Earnings Call",
      "url": "https://finnhub.io/api/news?id=f096cae9d8b892a0671095521c3339dfd375495aa09b5cdfdbb2d8d961fe6a99"
    }
  }
]